Estimate of absorbed dose based on two-dimensional autoradiographic information in internal radionuclide therapy.

In radiation therapies using radionuclides emitting short-range particles, such as radioimmunotherapy or boron neutron capture therapy, the biological effects are strongly affected by the heterogeneity of the absorbed dose distribution delivered to tumor cells. The three-dimensional (3D) information of the source distribution at the cellular level is required to accurately determine the absorbed dose distribution to the individual tumor cells. Two-dimensional distribution of cell and nuclide with a resolution of 1 microm can be obtained from individual tissue sections by microautoradiography. To obtain such information in 3D, an ideal approach would be to align the serial tissue sections from a block and analyze all of them. This is straightforward in theory, but extremely difficult in practice. Furthermore, every section in the block has to be processed and analyzed, and the usage of the data from this laborious work is very inefficient. An approach presented here is to estimate the absorbed dose based on individual sections without 3D reconstruction. It is realistically workable since it avoids the most difficult task of alignment for the serial tissue sections. In addition, the absorbed dose can be estimated based on a limited number of noncontiguous sections. The validity of this approach has been tested by a Monte Carlo simulation for two representative radionuclide configurations: (a) a uniform distribution of sources and (b) a cell membrane bound source distribution. With only a limited number of sampling sections, the uncertainties in the dose estimation were estimated to approximately 15% for short-range particles.

[1]  L. M. Cobb,et al.  Distribution of injected monoclonal antibody in lymphoma-infiltrated spleen. , 1989, Leukemia research.

[2]  J. Bernard,et al.  Boron Neutron Capture Therapy and Radiation Synovectomy Research at the Massachusetts Institute of Technology Research Reactor , 1992 .

[3]  J L Humm,et al.  Image analysis for the study of radionuclide distribution in tissue sections. , 1994, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[4]  L. M. Cobb,et al.  Internal dosimetry using data derived from autoradiographs. , 1993, Journal of Nuclear Medicine.

[5]  J. Humm,et al.  The spatial accuracy of cellular dose estimates obtained from 3D reconstructed serial tissue autoradiographs. , 1995, Physics in medicine and biology.

[6]  J L Humm,et al.  Dosimetric aspects of radiolabeled antibodies for tumor therapy. , 1986, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[7]  T K Johnson,et al.  MABDOSE. I: Characterization of a general purpose dose estimation code. , 1999, Medical physics.

[8]  L. M. Cobb,et al.  Nonuniformity of tumor dose in radioimmunotherapy. , 1990, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[9]  R Mohan,et al.  Three-dimensional dosimetry for radioimmunotherapy treatment planning. , 1993, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[10]  J. Robertson Methods of Assessment of Absorbed Dose in Clinical Use of Radionuclides, ICRU Report 32 , 1980 .

[11]  C S Chui,et al.  Implementation of a Monte Carlo dosimetry method for patient-specific internal emitter therapy. , 1997, Medical physics.

[12]  Z. Li,et al.  A comparative autoradiographic study demonstrating differential intratumor localization of monoclonal antibodies to cell surface (Lym-1) and intracellular (TNT-1) antigens. , 1990, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[13]  T. Johnson,et al.  MABDOSE. II: Validation of a general purpose dose estimation code. , 1999, Medical physics.

[14]  J. Humm,et al.  A model of cell inactivation by alpha-particle internal emitters. , 1993, Radiation research.

[15]  G Sgouros,et al.  Implementation and evaluation of patient-specific three-dimensional internal dosimetry. , 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[16]  J. Schlom,et al.  Radioimmunotherapy of athymic mice bearing human colon carcinomas with monoclonal antibody B72.3: histological and autoradiographic study of effects on tumors and normal organs. , 1987, European journal of cancer & clinical oncology.

[17]  S. Kennel Effects of target antigen competition on distribution of monoclonal antibody to solid tumors. , 1992, Cancer research.

[18]  W. Hawkins,et al.  Patient-specific dosimetry using quantitative SPECT imaging and three-dimensional discrete Fourier transform convolution. , 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[19]  E. Yorke,et al.  Direct dose confirmation of quantitative autoradiography with micro-TLD measurements for radioimmunotherapy. , 1988, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[20]  M. Ljungberg,et al.  Radiation dosimetry in nuclear medicine. , 1999, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine.

[21]  R K Ten Haken,et al.  Three‐dimensional reconstruction of monoclonal antibody uptake in tumor and calculation of beta dose‐rate nonuniformity , 1994, Cancer.